Work package 1.3
Hypothesis: Infant health is improved by adding probiotics or milk bioactives to infant formula.
Probiotics and bioactive formula
We aim to optimize milk formula for infants that cannot be breast-fed. Diets enriched with probiotics or bioactive milk proteins/lipids are compared with standard formula or breast milk at hospitals.
Methods
Double-blind, randomized-controlled trial with an exclusively breast-fed group plus three formula-fed groups. Inclusion criteria for formula groups are healthy infants (2.5-4.0 kg body weight) for which exclusive formula feeding is decided by their own mother before infant age 14 d. Infants with congenital diseases, or receiving anti-/pre-/probiotics, are excluded. Follow up until 13 months.
Results
Primary endpoints: Infections episodes (gastrointestinal and upper and lower respiratory
infections) in infants fed with infant formula containing probiotics compared with standard formula.
Synopsis
- Download synopsis for WP 1.3 - updated 2016
- Download synopsis for WP 1.3 - updated 2014
- Download synopsis for WP 1.3
Publications
NEOMUNE-related publications and background litterature.
Leaders for WP 1.3
- Janet Håkonsson
- Bo Lonnerdal
- Olle Hernell
Work package 1
WP 1.1
Caesarean birth affects the gut microbiota and infection resistance in infants
WP 1.2
Infant infection rates are associated with birth method, breast-feeding and antibiotics
WP 1.3
Infant health is improved by adding probiotics or milk bioactives to infant formula
WP 1.4
Human banked milk is superior to formula for growth/immunity in preterm infants
WP 1.5
Use of pro- or antibiotics improves feeding tolerance and health in preterm infants
WP 1.6
Early enteral feeding, with or without probiotics, supports preterm infant health
WP 1.7
Social, cultural and ethical values limit new dietary treatments for infants